---
title: "SANAI HEALTH GP released its annual performance report, with a shareholder loss of 22.04 million yuan, turning from profit to loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281214285.md"
description: "SANAI HEALTH GP released its annual results for the year ending December 31, 2025, with group revenue of 85.9 million yuan, a year-on-year increase of 0.8%. However, the loss attributable to shareholders was 22.04 million yuan, turning from profit to loss compared to the previous year, with a loss per share of 14.41 cents"
datetime: "2026-03-31T15:45:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281214285.md)
  - [en](https://longbridge.com/en/news/281214285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281214285.md)
---

# SANAI HEALTH GP released its annual performance report, with a shareholder loss of 22.04 million yuan, turning from profit to loss year-on-year

According to the Zhitong Finance APP, SANAI HEALTH GP (01889) released its annual performance for the year ending December 31, 2025, reporting revenue of RMB 85.9 million, a year-on-year increase of 0.8%; a loss attributable to shareholders of RMB 22.04 million, turning from profit to loss year-on-year; and a loss per share of 14.41 cents

### Related Stocks

- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [01889.HK](https://longbridge.com/en/quote/01889.HK.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)

## Related News & Research

- [China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025](https://longbridge.com/en/news/290539713.md)
- [Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial](https://longbridge.com/en/news/288172168.md)
- [China closing in but US still leads in biotech innovation, survey finds](https://longbridge.com/en/news/290431706.md)